CDSCO
- Status: likely_approved
🇮🇳 Tabrecta in India
Tabrecta (CAPMATINIB) regulatory status in India.
Marketing authorisation
Tabrecta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in India
Frequently asked questions
Is Tabrecta approved in India?
Yes. CDSCO has authorised it.
Who is the marketing authorisation holder for Tabrecta in India?
Novartis Pharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.